Capstone Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History

Capstone Financial Advisors, Inc.

  • $1.84 Billion
  • Q3 2025

A detailed history of Capstone Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 18,541 shares of BMY stock, worth $867,904. This represents 0.05% of its overall portfolio holdings.

Number of Shares
18,541
Previous 18,324 1.18%
Holding current value
$867,904
Previous $848,000 1.42%
% of portfolio
0.05%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$43.31 - $48.98 $9,398 - $10,628
217 Added 1.18%
18,541 $836,000
Q2 2025

Aug 08, 2025
BUY
$44.12 - $59.6 $25,457 - $34,389
577 Added 3.25%
18,324 $848,000
Q1 2025

May 09, 2025
SELL
$53.9 - $63.11 $5,497 - $6,437
-102 Reduced 0.57%
17,747 $1.08 Million
Q4 2024

Feb 14, 2025
SELL
$51.92 - $59.94 $238,053 - $274,824
-4,585 Reduced 20.44%
17,849 $1.01 Million
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $912 - $1,190
-23 Reduced 0.1%
22,434 $1.16 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $12,839 - $16,903
319 Added 1.44%
22,457 $932,000
Q1 2024

May 14, 2024
BUY
$47.98 - $54.4 $380,481 - $431,392
7,930 Added 55.81%
22,138 $1.2 Million
Q4 2023

Feb 13, 2024
SELL
$48.48 - $57.85 $2,714 - $3,239
-56 Reduced 0.39%
14,208 $729,000
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $23,213 - $25,956
-401 Reduced 2.73%
14,264 $827,000
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $61,416 - $68,193
964 Added 7.04%
14,665 $937,000
Q1 2023

May 12, 2023
BUY
$65.71 - $74.53 $14,981 - $16,992
228 Added 1.69%
13,701 $949,000
Q4 2022

Feb 15, 2023
SELL
$68.48 - $81.09 $76,149 - $90,172
-1,112 Reduced 7.62%
13,473 $969,000
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $16 - $9,835
-128 Reduced 0.87%
14,585 $1.04 Million
Q2 2022

Sep 02, 2022
SELL
$72.62 - $79.98 $42,264 - $46,548
-582 Reduced 3.81%
14,713 $1.13 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $458,333 - $549,582
7,455 Added 95.09%
15,295 $1.12 Million
Q4 2021

Feb 11, 2022
BUY
$53.63 - $62.52 $35,342 - $41,200
659 Added 9.18%
7,840 $489,000
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $5,029 - $5,891
85 Added 1.2%
7,181 $425,000
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $2,909 - $3,168
47 Added 0.67%
7,096 $474,000
Q1 2021

May 13, 2021
BUY
$59.34 - $66.74 $109,838 - $123,535
1,851 Added 35.61%
7,049 $445,000
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $77,833 - $88,199
1,348 Added 35.01%
5,198 $322,000
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $189,458 - $247,131
3,850 New
3,850 $247,000

Others Institutions Holding BMY

# of Institutions
2,679
Shares Held
1.58B
Call Options Held
28.2M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capstone Financial Advisors, Inc. Portfolio

Follow Capstone Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email